View attachment 9498
More than 55 percent of children ages 6 months to 2 years of age had a systemic
reaction, which is a response beyond the injection site, in response to their first dose of the Pfizer-BioNTech or Moderna COVID-19 vaccines, the CDC said on Sept. 1, and almost 60 percent had a reaction to the second dose of the Moderna vaccine.
While the most common systemic reactions were fatigue, fever, irritability, and crying, parents of more than 6 percent of the children in the study that was referenced said their child was unable to perform normal activities after the second dose of either the Pfizer-BioNTech or Moderna vaccine.
The data was collected by the CDC through a program called V-Safe—a smartphone-based monitoring system that operates through an app that parents download to their phones.
Between June 18 and Aug. 21, parents of more than 10,000 young children reported reactions to the CDC through V-Safe in the seven days after their child received a COVID-19 vaccination.
Parents of 8,338 children ages 6 months to 2 years who’d received the Moderna vaccine reported information through V-Safe, with 55.7 percent of them reporting a systemic reaction after the first dose, and about 58 percent after the second dose. For the Pfizer vaccine, parents of 4,749 children ages 6 months to 2 years submitted reports showing that 55.8 percent of them had a systemic reaction after the first dose and about 47 percent after the second dose of the vaccine...
About 10 percent of all children 6 months to 2 years were
reported to have a “health impact” after getting their first dose of either the Moderna or Pfizer vaccine. For the Moderna vaccine, slightly more children had a health impact after the second dose; for the Pfizer vaccine, it was slightly less.
The information was presented to the CDC’s Advisory Committee on Immunization Practices (ACIP) on Sept. 1 as part of an overview of all data related to the safety of COVID-19 vaccines.
In addition to V-Safe, data was presented summarizing reports from the
Vaccine Adverse Event Reporting System (VAERS) and also from the Vaccine Safety Data Link (VSD), which includes data from several large health maintenance organizations in the United States.
All three systems look at the safety of vaccines after they’ve already gone to market and have been administered to large numbers of people.
The information was presented by Tom Shimabukuro, the head of the CDC’s vaccine safety team, who told committee members that no “statistical signals” of COVID-19 vaccine reactions were found for young children in the VSD data.
He also said that systemic reactions were “commonly reported” following vaccines.
However, other medical professionals like Dr. Meryl Nass from Children’s Health Defense have expressed caution over the reported reactions, pointing to the high number of systemic reaction reports among very young children in response to the ACIP meeting.
www.medpagetoday.com
www.nature.com
www.jpost.com
www.vaccinedeaths.com
